NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice.

Xiang Li,Fengli Li,Yongli Chu,Xiaojie Wang,Hongyu Zhang,Yanyan Hu,Yan Zhang,Ziying Wang,Xinbing Wei,Wencheng Jian,Xiumei Zhang,Fan Yi
DOI: https://doi.org/10.1159/000356618
2013-01-01
Cellular Physiology and Biochemistry
Abstract:Background/Aims: Although the pathogenesis of myocardial infarction (MI) is multifactorial, activation of innate immune system to induce inflammation has emerged as a key pathophysiological process in MI. NOD2, one member of the NOD-like receptor (NLR) family, plays an important role in the innate immune response. This study was to examine the role of NOD2 during MI. Methods: MI was induced by permanent ligation of the left coronary artery in wild type and NOD2(-/-) mice and cardiac fibroblasts were isolated. Results: NOD2 expression was significantly increased in myocardium in post-MI mice. NOD2 deficiency improved cardiac dysfunction and remodeling after MI as evidenced by echocardiographic analysis, reduced the levels of cytokines, inflammatory cell infiltration and matrix metalloproteinase-9 (MMP-9) activity. In vitro, we further found that NOD2 activation induced the activation of MAPK signaling pathways, production of proinflammatory mediators and MMP-9 activity in cardiac fibroblasts. Conclusions: Our studies demonstrate that NOD2 is a critical component of a signal transduction pathway that links cardiac injury by exacerbation of inflammation and MMP-9 activity. Pharmacological targeting of NOD2-mediated signaling pathways may provide a novel approach to treatment of cardiovascular diseases. Copyright (C) 2013 S. Karger AG, Basel
What problem does this paper attempt to address?